Chemoinformaics analysis of 5alpha-Stigmastane-3,6-dione
| Molecular Weight | 428.701 | nRot | 6 |
| Heavy Atom Molecular Weight | 380.317 | nRig | 1 |
| Exact Molecular Weight | 428.365 | nRing | 4 |
| Solubility: LogS | -5.725 | nHRing | 0 |
| Solubility: LogP | 5.769 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 82.0401 |
| nHD | 0 | BPOL | 49.8899 |
| QED | 0.385 |
| Synth | 1.664 |
| Natural Product Likeliness | 0.301 |
| NR-PPAR-gamma | 0.054 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.27 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.637 |
| MDCK | 0.0000199 |
| BBB | 0.882 |
| PPB | 0.965746 |
| VDSS | 1.029 |
| FU | 0.0242307 |
| CYP1A2-inh | 0.926 |
| CYP1A2-sub | 0.362 |
| CYP2c19-inh | 0.616 |
| CYP2c19-sub | 0.252 |
| CYP2c9-inh | 0.391 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.061 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.38 |
| CYP3a4-sub | 0.094 |
| CL | 5.91 |
| T12 | 0.483 |
| hERG | 0.138 |
| Ames | 0.006 |
| ROA | 0.031 |
| SkinSen | 0.946 |
| Carcinogencity | 0.095 |
| EI | 0.975 |
| Respiratory | 0.876 |
| NR-Aromatase | 0.023 |
| Antiviral | No |
| Prediction | 0.691011 |